Douglas Scott Reintgen
#154,929
Most Influential Person Now
Douglas Scott Reintgen's AcademicInfluence.com Rankings
Douglas Scott Reintgenphilosophy Degrees
Philosophy
#8727
World Rank
#12162
Historical Rank
Logic
#5753
World Rank
#7178
Historical Rank

Download Badge
Philosophy
Douglas Scott Reintgen's Degrees
- Doctorate Medicine University of North Carolina at Chapel Hill
- PhD Cancer Biology University of North Carolina at Chapel Hill
Why Is Douglas Scott Reintgen Influential?
(Suggest an Edit or Addition)Douglas Scott Reintgen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. (2001) (2651)
- Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. (2001) (2315)
- Sentinel-node biopsy or nodal observation in melanoma. (2006) (1348)
- Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. (1996) (1323)
- Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. (1999) (1230)
- Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. (1999) (779)
- The Orderly Progression of Melanoma Nodal Metastases (1994) (733)
- gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. (2011) (645)
- Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. (2007) (612)
- Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial (2005) (589)
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial (2006) (530)
- Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. (1996) (505)
- Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. (1998) (491)
- Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. (1998) (450)
- A new American Joint Committee on Cancer staging system for cutaneous melanoma (2000) (428)
- Roles of activated Src and Stat3 signaling in melanoma tumor cell growth (2002) (426)
- An Evidence‐based Staging System for Cutaneous Melanoma 1 (2004) (420)
- Molecular staging of malignant melanoma: correlation with clinical outcome. (1998) (351)
- Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. (1998) (306)
- Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision‐making (1994) (301)
- Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy (1996) (297)
- Complications Associated With Sentinel Lymph Node Biopsy for Melanoma (2003) (289)
- Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin (1998) (287)
- Detection of Submicroscopic Lymph Node Metastases with Polymerase Chain Reaction in Patients with Malignant Melanoma (1994) (261)
- Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. (2001) (255)
- Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. (1993) (254)
- Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed? (2001) (249)
- Lessons learned from the Sunbelt Melanoma Trial (2004) (237)
- Importance of Lymphatic Mapping in Ductal Carcinoma in Situ (DCIS): Why Map DCIS? (2001) (232)
- Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. (1991) (228)
- Correlation Between Prognostic Factors and Increasing Age in Melanoma (2004) (213)
- The role of sentinel lymph node biopsy in breast cancer. (1999) (211)
- Sentinel Node Biopsy in Ductal Carcinoma In Situ Patients (2000) (210)
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. (2011) (195)
- Lethal “Thin” Malignant Melanoma: Identifying Patients at Risk (1988) (193)
- The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I) (2010) (188)
- Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. (2001) (185)
- Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. (2001) (175)
- Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. (1983) (173)
- Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. (2001) (171)
- Sentinel Lymph Node Biopsy for Head and Neck Melanomas (2003) (164)
- Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I) (2012) (163)
- Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. (1984) (158)
- Is incisional biopsy of melanoma harmful? (2005) (155)
- Sentinel Lymph Node Biopsy in Melanoma of the Head and Neck (1997) (153)
- Recent advances in the care of the patient with malignant melanoma. (1997) (151)
- Gender-Related Differences in Outcome for Melanoma Patients (2006) (141)
- Patterns of early recurrence after sentinel lymph node biopsy for melanoma. (2002) (139)
- Interval sentinel lymph nodes in melanoma. (2002) (137)
- Age and Body Mass Index May Increase the Chance of Failure in Sentinel Lymph Node Biopsy for Women with Breast Cancer (2002) (135)
- Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma (1998) (135)
- Lymphatic Mapping and Sentinel Lymph Node Biopsy (1999) (132)
- Malignant melanoma arising during pregnancy. A study of 100 patients. (1990) (130)
- Clinical patterns of metastasis (2006) (130)
- Pathologic examination of the sentinel lymph node in malignant melanoma. (1999) (129)
- New TNM melanoma staging system: linking biology and natural history to clinical outcomes. (2003) (128)
- Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. (2006) (128)
- Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. (2008) (122)
- Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study (2006) (121)
- Bleomycin-mediated electrochemotherapy of metastatic melanoma. (1996) (119)
- Tumor Biology of Infiltrating Lobular Carcinoma: Implications for Management (1995) (113)
- A Pilot Study Utilizing Intraoperative Lymphoscintigraphy for Identification of the Sentinel Lymph Nodes in Vulvar Cancer (1997) (112)
- Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. (2000) (111)
- Recurrent malignant melanoma: the identification of prognostic factors to predict survival. (1992) (109)
- Malignant melanoma and pregnancy (1985) (108)
- Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. (1997) (108)
- Malignant melanoma in black American and white American populations. A comparative review. (1982) (102)
- Touch preparation cytology of breast lumpectomy margins with histologic correlation. (1991) (101)
- Bleomycin-mediated electrochemotherapy of basal cell carcinoma. (1996) (97)
- Factors Associated with False-Negative Sentinel Lymph Node Biopsy in Melanoma Patients (2009) (97)
- Implementation of New Surgical Technology: Outcome Measures for Lymphatic Mapping of Breast Carcinoma (1999) (95)
- Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. (1995) (95)
- Lymphoscintigraphy in malignant melanoma. (1992) (94)
- Current status of sentinel lymph node mapping and biopsy: facts and controversies. (2003) (94)
- Age as a prognostic factor in the malignant melanoma population (1994) (93)
- Microstaging of Breast Cancer Patients Using Cytokeratin Staining of the Sentinel Lymph Node (1999) (91)
- The Use of Intraoperative Radiolymphoscintigraphy for Sentinel Node Biopsy in Patients with Malignant Melanoma (1996) (91)
- Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma (1997) (90)
- Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. (2007) (89)
- Lymphatic mapping in the treatment of breast cancer. (1998) (88)
- Sentinel Node Biopsy and Cytokeratin Staining for the Accurate Staging of 478 Breast Cancer Patients (1999) (87)
- The use of lymphoscintigraphy in melanoma of the head and neck. (1994) (85)
- Prognosis for recurrent stage I malignant melanoma. (1987) (84)
- Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. (2008) (84)
- Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy (2001) (84)
- The Progression of Melanoma Nodal Metastasis Is Dependent on Tumor Thickness of the Primary Lesion (1999) (84)
- Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. (2010) (83)
- Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. (2001) (82)
- Metastatic malignant melanoma with an unknown primary. (1983) (76)
- Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. (2003) (76)
- Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes (1998) (67)
- Tumor biology of infiltrating lobular carcinoma. Implications for management. (1995) (66)
- A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. (1998) (63)
- Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer (1998) (61)
- Multiple primary melanomas: Implications for screening and follow-up programs for melanoma (2006) (61)
- The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. (2001) (59)
- Breast cancer patients' personality style, age, and treatment decision making (1996) (58)
- The tumor biology of melanoma nodal metastases. (1996) (58)
- Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. (2002) (57)
- Detection of submicroscopic lymph node metastases in patients with melanoma. (1991) (56)
- ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. (2010) (55)
- Clinical relevance of internal mammary node mapping as a guide to radiation therapy. (2001) (55)
- Breast Cancer in Patients with Prior Augmentation: Presentation, Stage, and Lymphatic Mapping (2004) (55)
- Metastatic melanoma: chemotherapy to biochemotherapy. (2002) (54)
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? (2010) (52)
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy. (2016) (52)
- Radioguidance for nonpalpable primary lesions and sentinel lymph node(s). (2001) (52)
- Learning curves and breast cancer lymphatic mapping: institutional volume index. (2001) (50)
- Utility of Internal Mammary Lymph Node Removal When Noted by Intraoperative Gamma Probe Detection (2001) (50)
- The anatomy of missed breast cancers. (1993) (50)
- Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. (2000) (49)
- Final results of the department of defense multicenter breast lymphatic mapping trial (2002) (49)
- Learning curves and certification for breast cancer lymphatic mapping. (1999) (47)
- Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). (2000) (46)
- Ulceration as a Predictive Marker for Response to Adjuvant Interferon Therapy in Melanoma (2010) (45)
- Final results of the Sunbelt Melanoma Trial (2008) (44)
- Frequency of nonsentinel lymph node metastasis in melanoma (2007) (43)
- Molecular mechanisms of metastasis (2006) (42)
- Immunotherapy for melanoma. (2002) (42)
- Second Primary Melanomas: Incidence and Outcome (2010) (41)
- Sentinel Node Biopsy in Breast Cancer: An Overview (2000) (41)
- Cutaneous malignant melanoma. (2001) (41)
- Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. (1998) (41)
- The clinical relevance of molecular staging for melanoma. (2001) (40)
- National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. (2004) (40)
- The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma (1995) (39)
- The Role of Lymphoscintigraphy in the Management of the Patient With Breast Cancer (2001) (39)
- The new melanoma staging system. (2002) (38)
- Prognosis in malignant melanoma. (1998) (38)
- Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. (1999) (37)
- Lymphatic Mapping with Sentinel Lymph Node Biopsy in Patients with Breast Cancers <1 centimeter (T1A - T1B) (1999) (37)
- Thymolipoma in association with myasthenia gravis. (1978) (37)
- Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697). (2017) (37)
- Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma. (2014) (36)
- Sex related survival differences in instances of melanoma. (1984) (36)
- Identification of lymphatic drainage basins in patients with cutaneous melanoma. (1993) (33)
- The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. (1997) (33)
- Sentinel lymphadenectomy: a safe answer to less axillary surgery? (1998) (33)
- Cytology of lumpectomy specimens. (1991) (33)
- Techniques for lymphatic mapping in breast carcinoma. (1999) (33)
- Bilaterality and recurrence rates for lobular breast cancer: Considerations for treatment (1997) (33)
- Parotid selective lymphadenectomy in malignant melanoma. (1999) (32)
- Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: Clinical outcome (1997) (32)
- Radioguided surgery for the ultrastaging of the patient with melanoma. (1997) (32)
- Evaluation of new putative tumor markers for melanoma (1996) (30)
- The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. (2004) (30)
- Cutaneous melanoma of the head and neck. A review of 399 cases. (1983) (30)
- The Prognostic Significance of Nonsentinel Lymph Node Metastasis in Melanoma (2010) (30)
- Psychosocial aspects of melanoma. (1992) (30)
- Lymphatic mapping in breast cancer. (1999) (29)
- Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. (1998) (29)
- Cutaneous Melanoma of the Head and Neck: Advances in Evaluation and Treatment (2000) (28)
- More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques. (1996) (27)
- Diversity of Stage III Melanoma in the Era of Sentinel Lymph Node Biopsy (2013) (27)
- Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up (2010) (27)
- Evidence for a Better Nodal Staging System for Melanoma: The Clinical Relevance of Metastatic Disease Confined to the Sentinel Lymph Nodes (2013) (26)
- Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis. (2007) (26)
- Diseases of the Liver 6th Ed (1988) (26)
- Identification of submicroscopic lymph node metastases in patients with malignant melanoma. (1993) (26)
- The Number of Lymph Nodes Involved with Metastatic Disease Does Not Affect Outcome in Melanoma Patients as Long as All Disease Is Confined to the Sentinel Lymph Node (2009) (25)
- Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma (2006) (24)
- The role of sentinel lymph node mapping for melanoma. (1997) (24)
- The process of clinical trials: a model for successful clinical trial participation. (2001) (24)
- Controversial topics in breast lymphatic mapping. (2004) (23)
- Overall and progression-free survival in metastatic melanoma: analysis of a single-institution database. (2006) (23)
- Breast preservation in women with giant juvenile fibroadenoma. (2013) (23)
- Radiologic imaging in malignant melanoma: a review. (1993) (23)
- The promise of microarray technology in melanoma care. (2002) (22)
- Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. (1997) (22)
- Metastatic melanoma with an unknown primary. (1992) (22)
- Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma. (1997) (21)
- Importance of race on breast cancer survival (2006) (21)
- In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. (2000) (21)
- Etiology and prognosis of local recurrence in malignant melanoma of the skin. (1992) (21)
- Sentinel lymph node micrometastasis from melanoma (1999) (21)
- A phase 2 study of tasisulam sodium (LY573636 sodium) as second‐line treatment for patients with unresectable or metastatic melanoma (2011) (21)
- The evaluation of putative tumor markers for malignant melanoma. (1992) (20)
- Full-Thickness Grafts Procured from Skin Overlying the Sentinel Lymph Node Basin; Reconstruction of Primary Cutaneous Malignancy Excision Defects (2008) (20)
- Fine needle aspiration biopsy of palpable breast lesions. Review and statistical analysis of 1875 cases. (1993) (20)
- Breast Lymphatic Mapping and Sentinel Lymph Node Biopsy: State of the Art: 2015. (2016) (20)
- Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5 (1983) (20)
- The staging of malignant melanoma and the florida melanoma trial (2004) (19)
- Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study. (1992) (19)
- Radiologic, endoscopic and surgical considerations of malignant melanoma metastatic to the small intestine. (1984) (19)
- Prevalence of Additional Positive Lymph Nodes in Complete Lymphadenectomy Specimens after Positive Sentinel Lymphadenectomy Findings for Early-Stage Melanoma of the Head and Neck (2003) (19)
- Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010 (2010) (18)
- Erratum to: Axillary Recurrence Rate Following Negative Sentinel Node Biopsy for Invasive Breast Cancer: Long-Term Follow-Up (2010) (18)
- Detection of occult melanoma cells in sentinel lymph nodes and blood. (1997) (18)
- Lymphatic mapping and sentinel node harvest for malignant melanoma (1997) (18)
- Molecular analysis in evaluating the sentinel node in malignant melanoma. (2001) (18)
- Importance of Missed Axillary Micrometastases in Breast Cancer Patients (2001) (17)
- Malignant melanoma in the American black. (1983) (17)
- Comparison of Psychological Symptoms of Women Requesting Removal of Breast Implants with Those of Breast Cancer Patients and Healthy Controls (1997) (17)
- Regional node dissection for melanoma: techniques and indication. (2007) (17)
- Regional Nodal Surgery for Melanoma Impacts Recurrence Rates and Survival (2000) (16)
- Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma (2011) (16)
- Analysis of residual cancer after diagnostic breast biopsy: An argument for fine-needle aspiration cytology (1995) (16)
- Isolated limb perfusion for recurrent melanoma of the extremity. (1992) (16)
- Lymphoscintigraphy for malignant melanoma. Surgical considerations. (1983) (16)
- Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs. observation for sentinel node positive breast cancer. (2006) (16)
- The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award. (1989) (16)
- Lymphatic mapping and selective lymphadenectomy as an alternative to elective lymph node dissection in patients with malignant melanoma. (1998) (16)
- Imprint cytology of needle-localized breast lesions. (1993) (16)
- Investment in new technology research can save future health care dollars. (1997) (16)
- The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up (2012) (15)
- Histopathologic study of recurrent Clark level II melanomas. (1993) (15)
- Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods. (1984) (15)
- Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen (1995) (15)
- The current management and prognosis of acral lentiginous melanoma. (1992) (14)
- The medical legal implications of following mammographic breast masses. (1993) (14)
- Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. (1997) (14)
- Lymphatic mapping and sentinel lymph node biopsy for breast cancer. (2002) (13)
- Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases. (1998) (13)
- Juvenile malignant melanoma of the head and neck (1988) (13)
- Lymphatic mapping: a technique providing accurate staging for breast cancer (1999) (13)
- The changing face of malignant melanoma (2010) (12)
- Melanoma nodal metastases: biologic significance and therapeutic considerations. (1996) (12)
- Detection of occult lymph node metastases in malignant melanoma. (1992) (12)
- Worldwide experience with lymphatic mapping for invasive breast cancer. (2004) (12)
- Radioguided surgery for melanoma. (1999) (12)
- Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma (1998) (12)
- Renal artery stenosis in children. (1981) (12)
- Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. (1999) (12)
- Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion (2010) (12)
- Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials (2018) (11)
- Advances in local-regional treatment for patients with early-stage breast cancer: a review of the field. (2010) (11)
- Sentinel lymph node biopsy for breast cancer: Combined dye-isotope technique (2000) (11)
- Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study. (1992) (11)
- The role of elective lymph node dissection in malignant melanoma: who should undergo this nodal staging procedure? (1999) (11)
- Malignant melanoma and the prognostic implications of pregnancy, oral contraceptives, and exogenous hormones. (1993) (11)
- Chemotherapy for stage 4 melanoma: a three-year experience with cisplatin, DTIC, BCNU, and tamoxifen. (1993) (11)
- Natural history and clinical evaluation of the lumpectomy scar. (1993) (11)
- The concept of lymph node dissections in patients with malignant melanoma. (1992) (10)
- The Training of Surgeons in America (2001) (10)
- Pleomorphic lobular carcinoma in situ: treatment options for a new pathologic entity. (2012) (10)
- Changing standards of surgical care for the melanoma patient (1996) (10)
- The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. (1997) (10)
- The effectiveness of skin cancer screening and continuing medical education programs toward increasing the survival of patients with malignant melanoma. (1992) (10)
- Transplantation of insulinoma into the diabetic Syrian hamster. (1980) (9)
- Accurate staging of women with breast cancer (2002) (9)
- The role of lymphoscintigraphy in lymphatic mapping for melanoma and breast cancer. (1998) (9)
- Psychoneuroimmunology and Immune System Link for Stress, Depression, Health Behaviors, and Breast Cancer (1998) (9)
- Cutaneous Lymphatic Drainage in Patients With Grossly Involved Nodal Basins (1999) (9)
- Prevention and early detection of melanoma: a surgeon's perspective. (1993) (8)
- National protocols for lymphatic mapping. (1999) (8)
- The Next Revolution in General Surgery: Radioguided Surgery (1999) (8)
- Emerging Evidence for a Survival Benefit Associated With Regional Lymph Node Dissection for Melanoma (2000) (8)
- Molecular Staging of Melanoma (2004) (8)
- Molecular staging for patients with malignant melanoma. (2007) (8)
- Patterns of metastasis in human solid cancers. (2007) (7)
- Lymphatic mapping for melanomas of the upper extremity. (1999) (7)
- A phase II study of tasisulam sodium (LY573636) as second-line treatment for patients with unresectable or metastatic melanoma. (2010) (7)
- Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging (2019) (7)
- Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients With T1a, T1b Favorable Breast Cancer (2003) (7)
- Breast cancer screening in childhood cancer survivors. (2000) (6)
- Treatment of the primary in malignant melanoma of the skin. (1992) (6)
- The adjuvant treatment of malignant melanoma. (1997) (6)
- Historical perspectives and future applications. (1999) (6)
- Current management of melanoma patients with nodal metastases (2021) (6)
- Prognostic significance of the sentinel lymph node (SLN) in stage I or II melanoma patients: 368 (1997) (6)
- Hyperthermic isolated limb perfusion for extremity sarcomas. (2001) (6)
- In vivo and in vitro binding of iodinated monoclonal antibody A2B5 to RIN insulinoma cells. (1983) (6)
- IMMUNOLOGICAL CONSEQUENCES OF TRANSPLANTING RAT INSULINOMAS (1980) (5)
- Establishing a Standard of Care for the Patient with Melanoma (2001) (5)
- Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities (2017) (5)
- A myocutaneous flap for closure of upper arm amputations for uncontrolled axillary tumors (1991) (5)
- Lymphatic mapping for melanoma before and after wide local excision: 367 (1997) (5)
- Computer database for melanoma registry. A clinical management and research tool to monitor outcomes and ensure continuous quality improvement. (1996) (5)
- Localization of malignant melanoma using monoclonal antibodies. (1991) (5)
- Florida's undeclared epidemic: malignant melanoma. (1997) (5)
- Use Pre- and Intra-Operative Data To Predict Probability of Positive Non-Sentinel Lymph Nodes. (2009) (5)
- Cytochemistry of sex steroid receptors: A critique (2005) (4)
- Experimental trials of immunotherapy for malignant melanoma. (1991) (4)
- Role of fine needle aspiration cytology after lumpectomy. (1994) (4)
- The Florida Melanoma Trial I: A Prospective Multi-center Phase I/II Trial of Post-operative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-alpha in the Treatment of Advanced Stage III Melanoma (2008) (4)
- Metastatic melanoma to regional lymph nodes. (2000) (4)
- Expanding Indications for Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Breast Cancer Population (2001) (4)
- Molecular staging for melanoma and breast cancer. (1999) (4)
- Sentinel lymph node biopsy: results to date (2003) (4)
- Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy. (2016) (4)
- Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. (1993) (3)
- Nodal failure after lymphatic mapping (LM) and negative sentinel lymph node (SLN) biopsy in stage I or II melanoma patients: 101 (1997) (3)
- The results of complete lymph node dissections in 88 melanoma patients with positive sentinel nodes: 365 (1997) (3)
- The human genome project: a dream becoming a reality. (1999) (3)
- A melanoma vaccine that works? Evidence for a phase III national trial (1998) (2)
- Surgery for Melanoma Metastatic to the Gastrointestinal Tract (1999) (2)
- A molecular technique useful in the detection of occult metastases in patients with melanoma : rt-PCR analysis of sentinel lymph nodes and peripheral blood. (2001) (2)
- Lymphatic Mapping and Sentinel Node Biopsy in Breast Cancer-Reply (1997) (2)
- Medical-legal pitfalls for the breast surgeon: incomplete mammographic localization of suspicious lesions and the correlation between palpable and mammographic abnormalities. (1996) (2)
- Monoamine oxidase and catechol-o-methyltransferase activity in hamster and rat insulinomas (1979) (2)
- Hyperthermic isolated limb perfusion: evolving concepts in the treatment of extremity soft tissue sarcomas (2006) (2)
- Male Breast Cancer (2016) (1)
- Superficial Femoral Lymph Node Dissection After Positive Sentinel Lymphadenectomy for Early-Stage Melanoma of the Lower Extremity (2003) (1)
- The credentialing of American surgery (1997) (1)
- Is the clinically positive axilla in breast cancer really a contraindication to sentinel node biopsy (2005) (1)
- Innovative Cancer Screening Legislation (1992) (1)
- Abstract OT3-4-02: MINT I: Multi-Institutional Neo-adjuvant Therapy, MammaPrint Project I (2012) (1)
- Prognostic F actors A nalysis o f 1 7,600 M elanoma P atients: Validation o f t he A merican J oint C ommittee o n C ancer Melanoma S taging S ystem (2001) (1)
- Parotid gland sentinel lymphadenectomy in malignant melanoma: 142 (1997) (1)
- Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). (2022) (1)
- The credentialing of American surgery (2006) (1)
- BLEOMYCIN-MEDIATED ELECTRO-CHEMOTHERAPY OF METAS-TATIC MELANOMA (1996) (1)
- Treatment of the primary malignant melanoma: a review. (1993) (1)
- Continuous quality assessment program for the comprehensive breast cancer clinic (1992) (1)
- To Dissect or Not To Dissect?—That Is the Question (2002) (1)
- "Ultrastaging" of breast cancer in the sentinel lymph node era (2004) (1)
- Surgical management of primary melanoma (2000) (1)
- Comparison of techniques in locating sentinel nodes in patients with malignant melanoma: 366 (1997) (1)
- Letters to the editor [4] (multiple letters) (1998) (1)
- Clinical Practice Guidelines: Clinical Practice Guidelines for Melanoma (1997) (1)
- Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials (2018) (0)
- Conference Preview: Joint Cancer Conference 2000 I. Introduction (1999) (0)
- Original scientific articleInvited commentary (2000) (0)
- Histopathologic Assessment of Primary Melanomas in Sentinel Node Positive Patients. (1999) (0)
- RT-PCR of sentinel lymph node metastases in malignant melanoma patients: 117 (1997) (0)
- Early detection of circulating melanoma cells in peripheral blood by RT-PCR: 195 (1997) (0)
- Malignant melanoma and pregnancy. (1985) (0)
- Commentary on “Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases” (2001) (0)
- Hyperthermic Isolated Limb Perfusion for (2001) (0)
- Should Axillary Lymph Node Dissection be Done for Breast Cancer (2009) (0)
- Comparison of radiopharmaceuticals utilized in lymphoscintigraphy: 305 (1997) (0)
- A personal computer database for clinical management and research for malignant melanoma: 196 (1993) (0)
- QS109. Validation of a Clinical Prediction Rule for Patients' Likelihood of Requiring Post-Mastectomy Radiation Therapy (2009) (0)
- LYMPHATIC MAPPING AND SENTINEL NODE BIOPSY IN BREAST CANCER. AUTHORS' REPLY (1997) (0)
- A minimal incision approach to inguinal lymphadenectomy: 164 (1997) (0)
- The next issue of Cancer Control: Journal of the Moffitt Cancer Center will focus on radioguided surgery for cancer. Among the topics and authors are: (1997) (0)
- Intraoperative lymphatic mapping for melanoma: 117 (1993) (0)
- Prognosis of Melanoma-Reply (1983) (0)
- Use of intraoperative breast cancer sentinel lymph node (SLN) assay to predict of ≥4 positive (+) lymph nodes (LN). (2009) (0)
- Peripheral Soft Tissue Masses: Present Day Diagnosis and Treatment (2018) (0)
- An investigational rapid RT-PCR assay for the detection of metastasis in sentinel lymph nodes shows improved performance over frozen section H&E: Analysis by primary tumor characteristics (2007) (0)
- Ten Best Readings on Radioguided Surgery: The ten best recent articles in the medical literature relating to radioguided surgery are reviewed here. (1997) (0)
- Molecular Staging of Melanoma (1999) (0)
- Morning Session H Sentinel Lymp.h Node Biopsy for Breast Cancer: Combined Dye- Isotope Techmque (2000) (0)
- Functional and morphologic changes associated with insulinoma transplantation into diabetic rats. (1983) (0)
- A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy. (2003) (0)
- 2008 Cancer Committee Members (2009) (0)
- Current management of melanoma patients with nodal metastases (2021) (0)
- Malignant melanoma in the pediatric population (2015) (0)
- Detection of micrometastases in regional lymph nodes of melanoma patients: 324 (1993) (0)
- Surgical Approaches to Cutaneous Melanoma, Vol. 7 in the Pigment Cell Series (1986) (0)
- Generation of mathematical model to predict sentinel node involvement in malignant melanoma: 272 (1997) (0)
- Ten Best Readings in Melanoma (2002) (0)
- Self-assessment examination of the american academy of dermatology (Identification no. 899-211) (2000) (0)
- SS6-3 Technical Aspects of Sentinel Node Mapping and Detection of MicroMetastases in Malignant Melanoma and Breast Cancer (2000) (0)
- Electrochemotherapy as a treatment for melanoma and other cutaneous malignancies: 110 (1997) (0)
- Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma (1985) (0)
- The effectiveness of skin cancer screening and continuing education programs towards increasing the survival of patients with melanoma: 199 (1993) (0)
- Introduction: the future is now for radioguided surgery (2004) (0)
- "Times are changing". (1997) (0)
- Commentary on “Comprehensive Review of Sentinel Lymphadenectomy in Breast Cancer” (2000) (0)
- Accepted for Plenary & Parallel Sessions (2015) (0)
- Is Specimen Mammography Beneficial?—Invited Critique (2000) (0)
- Scientific paper Patterns of early recurrence after sentinel lymph node biopsy for melanoma (2002) (0)
- A redefinition of skin lymphatic drainage with the use of lymphoscintigraphy: implications for elective node dissection for melanoma (1993) (0)
- Breast cancer : conservative approach to the axilla for better staging (1997) (0)
- Molecular Staging of Malignant Melanoma (2013) (0)
- Will Rogers Phenomenon-Reply (1992) (0)
- Non‐Operative Observation of Mammographic Abnormalities: Medical Legal Implications (1995) (0)
- The promise of new technologies and therapies. (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Douglas Scott Reintgen?
Douglas Scott Reintgen is affiliated with the following schools: